NEW YORK (GenomeWeb News) – NanoString Technologies has closed a series C financing round, raising $30 million from venture capital investors.

The Seattle-based firm said the financing was completed through two tranches, and the funds will be used to accelerate commercialization of its nCounter Analysis System for research and diagnostic applications. The system is a digital gene-expression tool that can multiplex hundreds of genes per sample.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.